COMMUNIQUÉS West-GlobeNewswire

-
Progressive Care Begins to Take Action to Combat Naked Short Sellers
17/04/2018 - 16:11 -
Legally Blind Teen Can See Again, And Is Helping Visually Impaired Children See their Mothers For The First Time this Mother’s Day
17/04/2018 - 15:49 -
Family experience survey in Alberta provides voice for quality improvement in long-term care
17/04/2018 - 15:35 -
ASLAN Pharmaceuticals Announces Presentation of New Pre-Clinical Data on Varlitinib in Hepatocellular Carcinoma at AACR
17/04/2018 - 15:30 -
Dynavax Provides New Durability of Response Data for SD-101 in Combination with KEYTRUDA® (pembrolizumab) in Melanoma at the 2018 American Association for Cancer Research Annual Meeting
17/04/2018 - 15:07 -
Shire plc : FDA APPROVES VONVENDI® FOR PERIOPERATIVE MANAGEMENT OF BLEEDING IN ADULT PATIENTS WITH VON WILLEBRAND DISEASE
17/04/2018 - 15:00 -
Poseida Announces Initial Phase 1 Data for P-BCMA-101 CAR-T Stem Cell Memory Product in Patients with Relapsed/Refractory Multiple Myeloma
17/04/2018 - 15:00 -
Biomerica Announces Third Quarter Financial Results
17/04/2018 - 15:00 -
Maple Leaf Green World Inc. Receives Final Approval to List on the NEO Exchange and Delist Common Shares from the TSXV
17/04/2018 - 15:00 -
Sarah Boyce Joins Akcea Therapeutics as President and Member of the Board of Directors
17/04/2018 - 15:00 -
Akcea and Ionis Complete Licensing Transaction to Commercialize Inotersen for hATTR
17/04/2018 - 15:00 -
NSS Labs Announces 2018 Advanced Endpoint Protection Group Test Results
17/04/2018 - 15:00 -
Oncobiologics Appoints Randy Thurman to Board of Directors
17/04/2018 - 15:00 -
Cyclacel’s CYC065 CDK Inhibitor Demonstrates Synergy With Venetoclax By Dual Targeting Of Chronic Lymphocytic Leukemia
17/04/2018 - 15:00 -
Resverlogix Announces Proposed Offering of Units
17/04/2018 - 15:00 -
Hemispherx Successfully Completes Production of More Than 8,500 Vials of Ampligen for Commercial Sales and Expanded Clinical Programs
17/04/2018 - 14:30 -
HMS Holdings Corp. To Report First Quarter 2018 Financial and Operating Results
17/04/2018 - 14:30 -
Agritek Holdings Inc. Applauds New Deal With President Trump And Senator Cory Gardner Clearing Way For Colorado Medical And Recreational Cannabis Laws Including New Agritek Operations
17/04/2018 - 14:30 -
Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series™ Products That Provide Automated, Closed System Cellular Processing
17/04/2018 - 14:30
Pages